Terms ending in 2032
Every in-force patent on Biogen Ma Inc.'s record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,316,641 | Assay for JC Virus Antibodies In force · High confidence | Biogen Ma Inc. | In force | High confidence | |
| US 9,034,324 | Anti-Bcma Antibodies In force · High confidence | Biogen Ma Inc. | In force | High confidence | |
| US 9,340,527 | S1P Modulating Agents In force · High confidence | Biogen Ma Inc. | In force | High confidence | |
| US 9,808,449 | S1P modulating agents In force (reinstated) · High confidence | Biogen Ma Inc. | In force (reinstated) | High confidence | |
| US 10,034,869 | S1P Modulating Agents In force · High confidence | Biogen Ma Inc. | In force | High confidence | |
| US 10,406,144 | S1P Modulating Agents In force · High confidence | Biogen Ma Inc. | In force | High confidence | |
| US 10,894,040 | S1P Modulating Agents In force · Medium confidence | Biogen Ma Inc. | In force | Medium confidence | |
| US 11,079,393 | METHODS FOR DETERMINING DIFFERENCES IN ALPHA-4 INTEGRIN ACTIVITY BY CORRELATING DIFFERENCES IN sVCAM AND/OR sMAdCAM LEVELS In force · High confidence | Biogen Ma Inc. | In force | High confidence | |
| US 9,198,955 | Method for Reducing Flu-Like Symptoms Associated with Intramuscular Administration of Interferon Using a Fast Titration Escalating Dosing Regimen In force · High confidence | Biogen Ma, Inc. | In force | High confidence | |
| US 10,500,254 | Method for Reducing Flu-Like Symptoms Associated with Intramuscular Administration of Interferon Using a Fast Titration Escalating Dosing Regimen In force · High confidence | Biogen Ma, Inc. | In force | High confidence | |
| 12 more term ends in 2032 · Pro | |||||
10 of 22 patents shown. Soonest term end first, then patent number.
Pro members see all 22.
21 of these are in force and held by Biogen Ma Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.